|
Volumn 21, Issue 10, 2002, Pages 959-960
|
Postexposure prophylaxis against human immunodeficiency virus infection after sexual assault
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;
ANTIRETROVIRUS AGENT;
INDINAVIR;
LAMIVUDINE;
LAMIVUDINE PLUS ZIDOVUDINE;
NELFINAVIR;
STAVUDINE;
ZIDOVUDINE;
ANOREXIA;
CLINICAL FEATURE;
DRUG SAFETY;
DRUG TOLERABILITY;
DRUG WITHDRAWAL;
FOLLOW UP;
HEADACHE;
HEALTH CARE COST;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
INFECTION PREVENTION;
INFECTION RISK;
MALAISE;
MEDICAL DECISION MAKING;
NAUSEA;
POSTTRAUMATIC STRESS DISORDER;
PRESCRIPTION;
PRIORITY JOURNAL;
RISK MANAGEMENT;
SEXUAL CRIME;
SHORT SURVEY;
TREATMENT INDICATION;
TREATMENT OUTCOME;
VIRUS TRANSMISSION;
ADOLESCENT;
ANTI-HIV AGENTS;
FEMALE;
HIV INFECTIONS;
HUMANS;
MALE;
PROGNOSIS;
RAPE;
RISK ASSESSMENT;
RISK FACTORS;
SEXUALLY TRANSMITTED DISEASES, VIRAL;
TIME FACTORS;
TREATMENT OUTCOME;
UNITED STATES;
|
EID: 0036796096
PISSN: 08913668
EISSN: None
Source Type: Journal
DOI: 10.1097/00006454-200210000-00015 Document Type: Short Survey |
Times cited : (5)
|
References (14)
|